Brief: Patrys Expects Delay In Getting Components For Fermentation Media To Make PAT-DX1

Patrys

03/08/2021 02:13

Aug 3 (Reuters) - Patrys Ltd  PAB.AX :
    * MARKET UPDATE - PAT-DX1 CLINICAL TRIAL PREPARATION
    * ADVISED BY MANUFACTURER OF EXPECTED DELAYS IN PROCURING
KEY
COMPONENTS FOR FERMENTATION MEDIA USED FOR PAT-DX1 PRODUCTION
    * ENGINEERING RUN FOR PAT-DX1 IS NOW ANTICIPATED TO BE
DELAYED
UNTIL Q4 2021
    * EXPECTS IT WILL NOW SUBMIT A HUMAN RESEARCH ETHICS
APPLICATION
FOR PHASE 1 CLINICAL TRIAL IN H2 CY2022
    * START OF GMP TOXICOLOGY STUDIES FOR PAT-DX1 HAS BEEN
RESCHEDULED
TO Q1 CY2022
    * DELAYS DUE TO IMPACT OF COVID-19 ON GLOBAL REAGENT
PRODUCTION
AND SUPPLY CHAINS

Source text for Eikon:  ID:nASX3PYDCX 
Further company coverage:  PAB.AX 

 ((Reuters.Briefs@thomsonreuters.com;))